Barriers seem to persist in the adoption of the standard of care in metastatic castration-sensitive prostate cancer (mCSPC). All contemporary oncol......READ MORE
Our featured expert notes the importance of ensuring that the patient's voice is being heard throughout the development of clinical trial designs. ......READ MORE
In metastatic castration-resistant prostate cancer (mCRPC), effective disease control is key to preserving quality of life (QOL). Additionally, wit......READ MORE
Our featured expert describes a recent expansion in the number of daily oral therapies in genitourinary oncology, noting the importance of treatmen......READ MORE
Quality of life (QOL) and overall survival (OS) are 2 end points that are very important to patients with advanced prostate cancer. Our featured ex......READ MORE
